Skip to main content
. 2021 Jun 24;24(Suppl 2):e25705. doi: 10.1002/jia2.25705

Table 5.

Sociodemographic, psychosocial and HIV‐related correlates of anxiety symptoms among young people living with HIV from SSA

Author (year) Outcome Measure of effect (precision) Sociodemographic correlates Psychosocial correlates HIV‐related correlates
Risk indicators Protective indicators Risk indicators Protective indicators Risk indicators Protective indicators
Besthorn et al. (2018) [68] Anxiety symptoms β (Se) NR NR

NR

‐Higher social support: −0.16 (0.06) NR NR
Boyes et al. (2018) [69] Anxiety symptoms β (Se) NR

‐Better overall health: −0.18 (0.08)

‐Internalized stigma: 0.54 (0.07)

‐Past year emotional abuse: 1.17 (0.19)

‐History of sexual abuse: 1.08 (0.34)

‐Bullying victimisation: 0.15 (0.02)

‐Poor parental monitoring: 0.02 (0.01)

‐Anticipated stigma: 0.30 (0.08)

‐Self‐efficacy: −0.06 (0.02)

‐Positive parenting: −0.05 (0.01)

‐Access to clinic support group: −0.43 (0.14)

‐ART side effects: 0.51 (0.17) NR
Haas et al., 2020 [78] Anxiety symptoms AOR (95% CI) NR

‐Younger age:

10 to 12 years age group vs. 16 to 19 years age group = 0.05 (0.01 to 0.37)

13 to 15 years age group vs. 16 to 19 years group = 0.19 (0.06 to 0.56)

‐History of physical violence: 2.74 (1.09 to 6.85) NR NR NR
Hoare et al. (2019) [66] Anxiety symptoms β (95% CI) NR NR ‐Stressful life events: 0.72 (0.44 to 1.01) NR NR NR
West et al. (2018) [58] Anxiety symptoms APR (95% CI) NR NR NR ‐Higher social support: 0.30 (0.13 to 0.71) NR NR

APR, Adjusted prevalence ratio; ART, Antiretroviral therapy; CI, Confidence interval; NR, Not reported; Se, Standard error; β, Beta coefficients (adjusted).